Jie Zuo

701 total citations
22 papers, 525 citations indexed

About

Jie Zuo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jie Zuo has authored 22 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jie Zuo's work include Glioma Diagnosis and Treatment (4 papers), Microtubule and mitosis dynamics (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Jie Zuo is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Microtubule and mitosis dynamics (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Jie Zuo collaborates with scholars based in China, United Kingdom and United States. Jie Zuo's co-authors include Wanfu Xie, Jia Wang, Alafate Wahafu, David H. Phillips, Roger Patient, Long Yu, Philip Pinheiro, Volker M. Arlt, Maode Wang and Aldo Ciau‐Uitz and has published in prestigious journals such as Development, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Jie Zuo

22 papers receiving 523 citations

Peers

Jie Zuo
Comparison fields: 5 of 86
  • Molecular Biology 304
  • Cancer Research 148
  • Cell Biology 108
  • Oncology 90
  • Immunology 88
Replace Yiqing Chi with:
Yiqing Chi United States
Peter Breslin United States
Yuhui Liu China
Jianping Wang China
Suk‐young Lee South Korea
Yantang Wang China
Carmen G. Lechuga Spain
Crystal Cornelius United States
Luna Ge China
Kyoung Eun Baek South Korea
Yiqing Chi United States View profile →
Citations per field, relative to Jie Zuo
Jie Zuo · 1×
Citations per year, relative to Jie Zuo
Jie Zuo · 1×

Countries citing papers authored by Jie Zuo

Since Specialization
Citations

This map shows the geographic impact of Jie Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Zuo more than expected).

Fields of papers citing papers by Jie Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Zuo. The network helps show where Jie Zuo may publish in the future.

Co-authorship network of co-authors of Jie Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Zuo. A scholar is included among the top collaborators of Jie Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Zuo. Jie Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 37
3 20
4 19
5 16
6 21
7 11
8 2
9 26
10 23
11 8
12 4
13 43
14 18
15 49
16 48
17 10
18 45
19 33
20
Genotyping of patients with chronic hepatitis B in five cities of China
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026